Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunosuppressants are a class of drugs that inhibit or decrease the activity of the immune system. They are primarily used to prevent the body from rejecting transplanted organs and to treat various autoimmune diseases, where the immune system mistakenly attacks healthy tissues. They act by targeting different components of the immune response, such as T-cell activation, lymphocyte proliferation, or cytokine production. Use increases susceptibility to infections and other complications.
Immunosuppressants work by targeting different components of the immune response, such as T-cell activation, lymphocyte proliferation, cytokine production, or inflammation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunosuppressant.